Dergiler / The European Research Journal / 2019 / Cilt: 5 - Sayı: 5

Preoperative and postoperative features of non-functioning pituitary adenomas: a single center experience

Sayfa
827–835
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We recommend that operations should be performed in experienced centers, preoperative and postoperative endocrinological evaluations and long-term follow-up should be done.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The main purposes of surgical treatment for non-functioning pituitary adenomas are removal of the pressure on the surrounding structures, especially the hypophyseal gland and visual tissue, and the normalization of hypophyseal functions.
📊
Temel Bulgular & Veri:In our study, we retrospectively reviewed postsurgical follow-up of patients with non-functioning pituitary adenoma treated at our institution in a period of 15 years of monitoring and evaluated surgical success, complication rate and recurrence rates in accordance with the literature.
💡
Sonuç & Katkı:We recommend that operations should be performed in experienced centers, preoperative and postoperative endocrinological evaluations and long-term follow-up should be done.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2000 Verileri
⚙️Değişkenler:Pituitary adenoma · non-functioning · surgery

Abstract

Objectives: The main purposes of surgical treatment for non-functioning pituitary adenomas are removal of the pressure on the surrounding structures, especially the hypophyseal gland and visual tissue, and the normalization of hypophyseal functions. In our study, we retrospectively reviewed postsurgical follow-up of patients with non-functioning pituitary adenoma treated at our institution in a period of 15 years of monitoring and evaluated surgical success, complication rate and recurrence rates in accordance with the literature. Methods: This study included 55 patients who had undergone surgery between 2000 and 2014 and who were followed-up postoperatively at our center. Preoperative and postoperative anterior pituitary hormones, complete resection and recurrence and also postoperative recovery of endocrinological and ophthalmological functions were statistically evaluated using file data of the patients. Results: There were 33 (60%) males and 22 (40%) females. It was observed that the adenoma caused pressure on the optic chiasm in 11 patients and infiltrated cavernous sinus in 9 patients. Postoperative mean follow-up was 75.14 ± 43.01 months. Seventeen (30.9%) patients had recurrence after complete resection. Postoperative persistence and deterioration rates were 12.2% and 26.6% in adrenal insufficiency, 12.2% and 26.6% in central hypothyroidism, respectively, while 12.2% worsening in central hypogonadism. Ophthalmologic findings were resolved in 62.5% of patients and persisted in 37.5% of the patients. Conclusions: The adenoma size and experience of the surgeon in non-functioning pituitary adenomas are the most important factors affecting surgical success. We recommend that operations should be performed in experienced centers, preoperative and postoperative endocrinological evaluations and long-term follow-up should be done.

🔖

Bu Makaleye Atıf Yap

ŞİŞMAN, P., BİÇER, B., GÜL, Ö. Ö., CANDER, S., SOYAK, H., ERSOY, C. (2019). Preoperative and postoperative features of non-functioning pituitary adenomas: a single center experience. The European Research Journal, Cilt: 5 - Sayı: 5, 827–835. https://ajindex.com/articles/361352

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA 2017;317:516-24
  2. Tjörnstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, Rosen T, et al. The incidance rate of pituitary adenomas in western Sweden for the period 2001-2011. Eur J Endocrinol 2014;171:519-26
  3. Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 2006;154:753- 6
  4. Bonneville JF, Cattin F, Bonneville F. Imaging of pituitary adenomas. Presse Med 2009;38:84-91
  5. Mello PA, Naves LA, Pereira Neto A, Oliveira EH, Ferreira IC, Araújo Júnior AS, et al. Clinical and laboratorial characterization and post-surgical follow-up of 87patients with non-functioning pituitary macroadenomas. Arq Neuropsiquiatr 2013;71:307-12
  6. Dekkes OM, Hammer S, deKeiser RJW, Roelfsema F, Schutte PJ, Smit JW, et al. The naturel course of non-functioning pituitary macroadenomas. Eur J Endocrinol 2007;156:217-24
  7. Greenman Y, Stern N. Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab 2009;23:625-38
  8. Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, et al; Endocrine Society. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:894-904
  9. Messerer M, Dıbourg J, Raverot G, Bervini D, Berhouma M, George I, et al. Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic. Clin Neurolo Neurosurg 2013;115:2514-20
  10. Maartens NE, Kaye AH. Role of transcranial approachs in the treatment of sellar and suprasellar lesions. Front Horm Res 2006;34:1-28
  11. Ferreira JE, de Mello PA, de Magalhaes AV, Botelho CH, Naves LA, Nosé V, et al. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry]. Arq Neuropsiquatr 2005;63:1070-1078. [Article in Portuguese] [12] Korbonits M, Carlsen E. Recent clinical and pathophysiological advances in non-functioning pituitary adenomas. Horm Res 2009;71 Suppl 2:123-30
  12. Hirohata T, Ishii Y, Matsuno A. Treatment of pituitary carcinomas and atypical pituitary adenomas: a review. Neurol Med Chir (Tokyo) 2014;54:966-73
  13. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007;156:203-16
  14. Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K,